Study #: 2667 | Published: 08/2010 | Pages: 239 | Individual User License: US$ 4,700

US demand for vaccines will advance 5.6 percent annually through 2014, driven by the development of new vaccines to treat complex human diseases, such as cancer. Public health recommendations for adult and adolescent immunization will produce continued strong sales in this segment, which has reached the level of pediatric vaccines sales.

This study analyzes the $10.8 billion US vaccines industry. It presents historical demand data for the years 1999, 2004 and 2009, and forecasts for 2014 and 2019 by vaccine type (e.g., pediatric, adult and adolescent, pandemic influenza, biodefense, developmental, travel, livestock, companion animal, poultry).

The study also considers market environment factors, details industry structure, evaluates company market share and profiles 18 industry competitors, including Sanofi-Aventis, Merck and GlaxoSmithKline.

Our Simple Buying Process

Add This Study To Your Cart.

Register, Checkout and
Verify Payment.

Your Report Is Available.

Table of Contents

Introduction viii

Executive Summary

Market Environment


Macroeconomic Outlook

Demographic Patterns

Health Care Trends

Health Insurance & Reimbursement

Medical Conditions

Chronic Conditions

Acute Conditions

Reportable Diseases

National Health Expenditures

Medical Facilities & Professionals

Patient Activity

Animal Health Care

Animal Demographic Trends

Veterinarians & Other Veterinary Workers

Animal Health Expenditures

Regulatory Considerations

Human Vaccines Regulation

Animal Vaccines Regulation

Vaccine Technologies


Technologies Used in Currently Licensed Products

Technologies Under Development


Valence & Combined Vaccines


Product Overview


Major Product Groups

Human Vaccines

Recommended Childhood Immunizations

Recommended Adult & Adolescent Immunizations

Animal Vaccines

Historical Market Trends

International Activity & Foreign Trade

Human Vaccines Trade

Animal Vaccines Trade

Human Vaccines


Pediatric Vaccines

Combination Vaccines

Diphtheria-Tetanus-Pertussis (DTaP)

Measles-Mumps-Rubella (MMR)

Other Combination Vaccines

Pneumococcal (PCV)




Haemophilus b (Hib)

Pediatric Seasonal Influenza


Adult & Adolescent Vaccines

Seasonal Influenza Vaccines

Human Papillomavirus

Tetanus-Diphtheria-Pertussis (Tdap)




Herpes Zoster

Other Adult & Adolescent Vaccines



Lyme Disease

Pandemic Influenza Vaccines




Travel Vaccines

Developmental Vaccines


Prostate Cancer

Lung Cancer

Other Cancers

Other Developmental Vaccines


Respiratory Syncytial Virus (RSV)

Alzheimer's Disease

All Other Developmental Vaccines

Animal Vaccines


Livestock Vaccines

Bovine Vaccines

Porcine Vaccines

Ovine Vaccines

Companion Animal Vaccines

Canine Vaccines

Feline Vaccines

Equine Vaccines

Other Companion Animal Vaccines

Poultry Vaccines

Other Animal Vaccines

Industry Structure


Market Share

Competitive Strategies

Mergers & Acquisitions

Licensing & Related Agreements

Research & Development


Marketing & Distribution

Company Profiles

AstraZeneca plc

Baxter International Incorporated

Biogen Idec Incorporated

Boehringer Ingelheim GmbH

Crucell NV

Dow Chemical Company

DynPort Vaccine Company LLC

Emergent BioSolutions Incorporated

GenVec Incorporated

GlaxoSmithKline plc

Heska Corporation

Intervet/Schering-Plough Animal Health, see Merck

MedImmune LLC, see AstraZeneca

Merck & Company Incorporated

Merial Limited, see Sanofi-Aventis

Novartis AG

Pfizer Incorporated

PharmAthene Incorporated


VaxGen Incorporated

VaxInnate Corporation

Wyeth, see Pfizer

Additional Companies Mentioned in the Study

List of Tables

Executive Summary

Summary Table

Market Environment

Macroeconomic Indicators

Population & Households

Health Insurance Coverage of the US Population

Chronic Conditions by Type

Acute Conditions by Type

Specified Reportable Diseases

National Health Expenditures

Selected Medical Facilities & Professionals

Patient Activity

Animal Population

Animal Health Employment

Animal Health Expenditures

Vaccine Technologies

US Licensed Vaccines by Production Technology

Product Overview

Vaccines Demand by Major Product Group

Human Vaccines Licensed for US Sale

2010 CDC-Recommended Childhood Immunizations

2010 CDC-Recommended Adolescent Immunizations

2010 CDC-Recommended Adult Immunizations

Vaccines Market, 1999-2009

US Trade in Vaccines

US Trade in Human Vaccines

US Trade in Animal Vaccines

Human Vaccines

Human Vaccines Demand

Pediatric Vaccines Demand by Type

Pediatric Combination Vaccines Demand

Diphtheria, Tetanus & Pertussis (DTaP Combination Vaccines Demand

Measles, Mumps & Rubella (MMR Combination Vaccines Demand

Other Combination Vaccines Demand

Pediatric Pneumococcal Vaccines Demand

Varicella Vaccines Demand

Rotavirus Vaccines Demand

Pediatric Hepatitis A & B Vaccines Demand

Haemophilus b (Hib) Vaccines Demand

Pediatric Seasonal Influenza Vaccines Demand

Polio Vaccines Demand

Adult & Adolescent Vaccines Demand by Group & Condition

Adult & Adolescent Seasonal Influenza Vaccines Demand

Human Papillomavirus (HPV) Vaccines Demand

Tetanus-Diphtheria-Pertussis (Tdap) Vaccines Demand

Meningococcal Vaccines Demand

Adult & Adolescent Pneumococcal Vaccines Demand

Adult & Adolescent Hepatitis A & B Vaccines Demand

Herpes Zoster Vaccines Demand

Other Adult & Adolescent Vaccines Demand

Pandemic Influenza Vaccines Demand

Biodefense Vaccines Demand

Travel Vaccines Demand

Developmental Vaccines Demand

Cancer Vaccines Demand

Other Developmental Vaccines Demand

Animal Vaccines

Animal Vaccines Demand

Livestock Vaccines

Companion Animal Vaccines Demand

Poultry Vaccines Demand

Other Animal Vaccines Demand

Industry Structure

US Vaccines Revenues by Company, 2009

Selected Acquisitions & Divestitures

Selected Cooperative Agreements

List of Charts

Industry Structure

US Human Vaccines Market Share by Company, 2009

US Animal Vaccines Market Share by Company, 2009

© by The Freedonia Group, Inc.